Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa.

Journal of Bacteriology
J E CadieuxA M Kropinski

Abstract

Pseudomonas aeruginosa PAO grown in glucose mineral salts medium released lipopolysaccharide which was chemically and immunologically similar to the cellular lipopolysaccharide. In addition, it possessed identical phage E79-inactivating properties. Through neutralization of phage activity and hemolysis inhibition assays, the organism was found to liberate lipopolysaccharide at a constant rate during log-phase growth equivalent to 1.3 to 2.2 ng/10(8) cells over a growth temperature range of 25 to 42 degrees C. At 19 degrees C, a lipopolysaccharide was released which was deficient in phage-inactivating activity but retained its immunological properties. Chemical analysis of lipopolysaccharide extracted from cells grown at 19 degrees C showed a deficiency in the O-side-chain component fucosamine. Gel exclusion chromatography of the polysaccharide fraction derived from lipopolysaccharide isolated from cells grown at 19 degrees C exhibited a decreased content of side-chain polysaccharide as well as a difference in the hexosamine:hexose ratio. The results of sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis confirmed these results as well as establishing that an essentially normal distribution of side-chain repeating...Continue Reading

References

Oct 15, 1975·European Journal of Biochemistry·I R Chester, P M Meadow
Jan 1, 1976·Canadian Journal of Microbiology·K G Johnson, M B Perry
Oct 1, 1976·The Journal of General Virology·K Jarrell, A M Kropinski
Dec 1, 1975·Canadian Journal of Microbiology·K G JohnsonR R Russel
Nov 1, 1973·The Journal of Experimental Medicine·I W Devoe, J E Gilchrist
Jun 3, 1967·Nature·M J CrutchleyJ Cameron
Dec 1, 1971·Analytical Biochemistry·A R Johnson
Jul 4, 1980·Journal of Chromatography·E A Ryan, A M Kropinski
Sep 1, 1963·Proceedings of the National Academy of Sciences of the United States of America·M J OSBORN
Jul 1, 1950·Journal of Bacteriology·B D DAVIS, E S MINGIOLI

❮ Previous
Next ❯

Citations

Jan 1, 1990·Critical Reviews in Microbiology·Y A Knirel
Jul 9, 2004·Applied and Environmental Microbiology·Eduardo Mora Bejarano, René Peter Schneider
Jan 4, 2012·FEMS Microbiology Reviews·Ethan E Mann, Daniel J Wozniak
Jan 1, 1989·Scandinavian Journal of Infectious Diseases. Supplementum·B M Andersen
Feb 1, 1987·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·K Pekkola-HeinoA Toivanen
Sep 15, 2005·Journal of Bacteriology·Wook Kim, Michael G Surette
Sep 12, 2019·Viruses·Kirk Osmond DouglasMarquita Gittens-St Hilaire
Mar 1, 1993·Research in Microbiology·D HozborO Yantorno
Dec 1, 1986·Journal of Bacteriology·W StuerU K Winkler
Jun 1, 1994·Antimicrobial Agents and Chemotherapy·J M PrinsP Speelman
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M GaldieroC Romano Carratelli
Apr 25, 2017·Journal of the American Chemical Society·Bastian RuehleJeffrey I Zink
Nov 14, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·P B Williams, J F Halsey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.